v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss from continuing operations $ (6,555,492) $ (15,551,291) $ (17,518,873) $ (7,039,604)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization of intangible assets 1,126,905 302 94,443 611
Credit loss provision 1,650,000    
Amortization of operating lease right-of-use asset 34,688 33,628 64,388 122,553
Stock-based compensation and service expense 703,372 761,698 1,816,462 521,509
(Income) loss from equity method investment (392,677) (392,677) 846,588
Distribution of earnings from equity method investment     611,888
Amortization of debt issuance costs and debt discount 254,741 1,064,357 1,136,412 1,291,814
Change in fair market value of derivative liability 1,275,237 (446,816) (538,213) (374,365)
Impairment of laboratory equipment     111,033
Debt modification charge     688,794
Loss on extinguishment of debt 9,076,587 9,076,587
Changes in operating assets and liabilities:        
Security deposit 17,332 17,491
Prepaid expense and other assets 41,612 (264,109) (22,299) (106,999)
Accrued liabilities and other payables (407,430) 1,295,813 1,750,047 (1,205,676)
Accrued liabilities and other payables - related parties     (14,051)
Operating lease obligation (29,688) (33,628) (64,388) (122,553)
NET CASH USED IN OPERATING ACTIVITIES FROM CONTINUING OPERATIONS (3,556,055) (2,788,804) (4,580,620) (4,668,458)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Payment for equity interest purchase     (100,000)
Cash acquired on acquisition 561,000 95,000 14,026
Purchase of property and equipment (12,158)    
Acquisition of internal-use software (233,449)    
Proceeds from sale of equity method investment     1,069,000
NET CASH PROVIDED BY INVESTING ACTIVITIES FROM CONTINUING OPERATIONS 315,393 95,000 1,083,026 (100,000)
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from issuance of convertible debt and warrants     3,367,750
Proceeds from issuance of convertible debt     200,000
Payments of convertible debt issuance costs     (282,700)
Repayments of bridge loan (375,000)    
Repayments of convertible debt (200,000) (3,388,222)
Proceeds from issuance of debt 1,564,000    
Payments of debt issuance costs (44,000)    
Repayments of debt (341,250)    
Proceeds from stock subscription liability 150,000    
Advance from pending sale of subsidiary 149,972    
Payments of offering costs (22,336)    
Proceeds from warrant exercises 254    
Proceeds received from the February 2026 private offering 3,249,412    
Disbursements for the February 2026 private offering costs (492,600)    
Repayments of loan payable - related party     (400,000)
Proceeds from stock subscription liability     150,000
Advance from pending sale of noncontrolling interest in subsidiary     49,972 2,122,392
Proceeds from issuance of convertible preferred stock     300,000 3,500,000
Payments of convertible preferred stock issuance costs     (10,000)
Proceeds from issuance of bridge loan     300,000
Proceeds from issuance of common stock and warrants 786,601   475,500
Payments of offering costs     (64,652)
Proceeds from equity offering     2,857,852
Disbursements for equity offering costs     (138,405)
NET CASH PROVIDED BY FINANCING ACTIVITIES FROM CONTINUING OPERATIONS 3,360,816 277,636 1,400,820 7,638,667
DISCONTINUED OPERATIONS        
Net cash used in operating activities from discontinued operations (231,956) (173,555) (407,434) (289,965)
Net cash used in investing activities from discontinued operations     (35,865)
NET CASH FLOWS USED IN DISCONTINUED OPERATIONS (231,956) (173,555) (443,299) (289,965)
EFFECT OF EXCHANGE RATE ON CASH - CONTINUING OPERATIONS 41,932 409 (9,018) 1,447
NET (DECREASE) INCREASE IN CASH (69,870) (2,589,314) (2,549,091) 2,581,691
CASH - beginning of period 109,091 2,658,182 2,658,182 76,491
CASH - end of period 39,221 68,868 109,091 2,658,182
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Interest 256,175 493,711 916,643 1,088,512
NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Common stock issued for future services 32,445 34,423 8,530
Common stock issued for accrued liabilities 96,600 42,385 42,385 60,000
Options issued for accrued liabilities 20,306    
Receivable related to sale of equity method investment 1,745,000 1,745,000
Related party payable extinguished upon sale of equity method investment 632,916 632,916
Series B Convertible Preferred Stock extinguished related to sale of equity method investment 11,000,000 11,000,000
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock 9,000,000 9,000,000
Stock warrants issued as placement agent fee 294,001    
Warrants issued as convertible note payable finder’s fee     40,900
Warrants issued with convertible note payable recorded as debt discount     438,568
Common stock issued as convertible note payable commitment fee     26,800 320,546
Equity method investment payable paid by a related party     566,667
Reclassification of deferred offering costs     175,136
Settlement of derivative liability 1,281,603 176,529 176,529 2,354
Issuance of common stock upon cashless exercise of stock warrants 127 43 43 4
Issuance of common stock upon cashless exercise of pre-funded stock warrants 35    
Initial ROU asset and lease liability 169,743 127,486 127,486
Conversion of convertible note payable and accrued interest into common stock 551,474 285,113 2,244,622
Series C Convertible Preferred Stock converted into common stock 1,250,000    
Series D Convertible Preferred Stock converted into common stock 8,837,527    
Series E Convertible Preferred Stock converted into common stock 103,500    
Related party gain on deconsolidation of Avalon RT 9 1,861,266    
Deferred financing costs in accrued liabilities 62,316 45,000
Issuance of common stock upon waiver to enter into note agreement 58,200    
Common stock issued as note payable commitment fee $ 138,000    
Legal fees recorded to receivable from sale of equity method investment     50,000
Reclassification of related party loan payable and accrued expenses to advance from related party     500,000
Shares issued for adjustments for 1:15 reverse split     21
Bridge loan issuance costs in accrued liabilities     18,846
Common stock issued as convertible note payable commitment fee included in accrued liabilities     $ 138,000